Change of Name

Recorded: 2010-11-18 Pages: 5

Assignor

SEPRACOR INC.

Executed: 2010-10-12

Assignee

SUNOVION PHARMACEUTICALS INC.

84 WATERFORD DRIVE, MARLBOROUGH, MASSACHUSETTS, 01752

Covered Properties (7)

Methods and Compositions for Treating Pulmonary Disorders Using Optically Pure (R,R)-Formoterol

Patent: 5,795,564 →

Application: 08/613,382 →

Methods and Compositions for Treating Pulmonary Disorders Using Optically Pure (R, R) Formoterol

Patent: 6,068,833 →

Application: 09/136,109 →

Aerosol Formulations Containing Micronized Optically Pure (R,R) Formoterol for Bronchodilating Therapy

Patent: 6,299,863 →

Application: 09/535,200 →

Methods and Compositions for Treating Pulmonary Disorders Using Optically Pure (R, R) Formoterol

Patent: 6,589,508 →

Application: 09/927,008 →

Methods and Compositions for Treating Pulmonary Disorders Using Optically Pure (R,R) -Formoterol

Patent: 6,866,839 →

Application: 10/457,123 →

Publication: US 2003/0203970

Methods and Compositions for Treating Pulmonary Disorders Using Optically Pure (R,R)-Formoterol

Patent: 7,368,120 →

Application: 11/046,936 →

Publication: US 2005/0131072

Methods and Compositions for Treating Pulmonary Disorders Using Optically Pure (R,R)-Formoterol

Patent: 8,062,627 →

Application: 12/048,068 →

Publication: US 2008/0161411

Related Assignments (1)

Other recorded transfers of the patents in this record — the chain of ownership.